{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T09:56:51Z","timestamp":1770890211879,"version":"3.50.1"},"reference-count":26,"publisher":"Public Library of Science (PLoS)","issue":"7","license":[{"start":{"date-parts":[[2022,7,6]],"date-time":"2022-07-06T00:00:00Z","timestamp":1657065600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001713","name":"European and Developing Countries Clinical Trials Partnership","doi-asserted-by":"publisher","award":["RIA2017S \u2013 2014"],"award-info":[{"award-number":["RIA2017S \u2013 2014"]}],"id":[{"id":"10.13039\/501100001713","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:sec id=\"sec001\">\n<jats:title>Introduction<\/jats:title>\n<jats:p>Recurrent parasitic infections may influence the immune response to vaccines. In the Partnership for Research on Ebola VACcinations extended follow-UP and clinical research capacity build-UP (PREVAC-UP) study being undertaken in Mambolo, northern Sierra Leone, participants are being followed up to assess the potential impact of exposure to malaria and\/or helminth infections on long-term immune response to two Ebola vaccines. To support the development of the assays that will be used in this evaluation, a parasitological survey was conducted in Mambolo between November 2019 and February 2020.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec002\">\n<jats:title>Methods<\/jats:title>\n<jats:p>Healthy individuals aged \u22651 year who were resident in Mambolo Chiefdom were selected using a stratified sampling approach and questionnaires were administered to explore their sociodemographic characteristics. Microscopy was used to detect malaria parasites, intestinal helminths and urinary schistosome infections. Rapid blood tests were used to detect infections with <jats:italic>Onchocerca volvulus<\/jats:italic> and <jats:italic>Wuchereria bancrofti<\/jats:italic>. We estimated the overall prevalence of these infections and used adjusted logistic regression models to explore risk factors for malaria and hookworm infection.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec003\">\n<jats:title>Results<\/jats:title>\n<jats:p>Eight hundred and fifteen (815) residents, 50.9% of whom were female were surveyed. Overall, 309 (39.1%) of 791 persons tested for malaria had a positive blood slide; <jats:italic>Plasmodium falciparum<\/jats:italic> was the dominant species. Helminth infection was detected in 122 (15.0%) of 815 stool samples including three mixed infections. The helminth infections comprised 102 (12.5%) cases of hookworm, 11 (1.3%) cases of <jats:italic>Trichuris trichiura<\/jats:italic>, 10 (1.2%) cases of <jats:italic>Schistosoma mansoni<\/jats:italic> and two (0.2%) cases of <jats:italic>Ascaris lumbricoides<\/jats:italic>. Being male (OR = 2.01, 95% CI 1.15\u20133.50) and residing in a non-riverine community (OR = 4.02, 95%CI 2.32\u20136.98) were the factors associated with hookworm infection. <jats:italic>Onchocerca volvulus<\/jats:italic> and <jats:italic>Wuchereria bancrofti<\/jats:italic> infections were found in 3.3% and 0.4% of participants respectively.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec004\">\n<jats:title>Conclusion<\/jats:title>\n<jats:p>Malaria and hookworm are the most prevalent parasite infections and those most likely to influence long-term immune response to Ebola vaccines among the trial participants.<\/jats:p>\n<\/jats:sec>","DOI":"10.1371\/journal.pone.0270968","type":"journal-article","created":{"date-parts":[[2022,7,6]],"date-time":"2022-07-06T17:35:53Z","timestamp":1657128953000},"page":"e0270968","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":10,"title":["Prevalence of malaria and helminth infections in rural communities in northern Sierra Leone, a baseline study to inform Ebola vaccine study protocols"],"prefix":"10.1371","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0141-6561","authenticated-orcid":true,"given":"Frank","family":"Baiden","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suzanne","family":"Fleck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bailah","family":"Leigh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philip","family":"Ayieko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Tindanbil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tuda","family":"Otieno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bolarinde","family":"Lawal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mattu","family":"Tehtor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maariam","family":"Rogers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lazarus","family":"Odeny","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1776-7641","authenticated-orcid":true,"given":"Mary H.","family":"Hodges","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mustapha","family":"Sonnie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohamed","family":"Samai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Ishola","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brett","family":"Lowe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deborah","family":"Watson-Jones","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brian","family":"Greenwood","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2022,7,6]]},"reference":[{"key":"pone.0270968.ref001","volume-title":"Demographic and Health Survey 2019","author":"Statistics Sierra Leone","year":"2020"},{"key":"pone.0270968.ref002","volume-title":"Situation Report Ebola Virus Disease","author":"World Health Organisation","year":"2016"},{"issue":"1","key":"pone.0270968.ref003","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1186\/s13063-021-05035-9","article-title":"Partnership for Research on Ebola VACcination (PREVAC): protocol of a randomized, double-blind, placebo-controlled phase 2 clinical trial evaluating three vaccine strategies against Ebola in healthy volunteers in four West African countries.","volume":"22","author":"M Badio","year":"2021","journal-title":"Trials"},{"issue":"10149","key":"pone.0270968.ref004","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/S0140-6736(18)31710-0","article-title":"Prevention of Ebola virus disease through vaccination: where we are in 2018","volume":"392","author":"Y Levy","year":"2018","journal-title":"Lancet"},{"issue":"suppl_1","key":"pone.0270968.ref005","doi-asserted-by":"crossref","first-page":"S6","DOI":"10.1093\/infdis\/jiy020","article-title":"The Sierra Leone Trial to Introduce a Vaccine Against Ebola: An Evaluation of rVSVG-ZEBOV-GP Vaccine Tolerability and Safety During the West Africa Ebola Outbreak","volume":"217","author":"M Samai","year":"2018","journal-title":"J Infect Dis"},{"issue":"9996","key":"pone.0270968.ref006","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/S0140-6736(15)61117-5","article-title":"Efficacy and effectiveness of an rVSV-vectored vaccine expressing Ebola surface glycoprotein: interim results from the Guinea ring vaccination cluster-randomised trial","volume":"386","author":"AM Henao-Restrepo","year":"2015","journal-title":"Lancet"},{"issue":"20","key":"pone.0270968.ref007","doi-asserted-by":"crossref","first-page":"10178","DOI":"10.1073\/pnas.1817329116","article-title":"Ebola vaccination in the Democratic Republic of the Congo","volume":"116","author":"CR Wells","year":"2019","journal-title":"Proc Natl Acad Sci U S A"},{"key":"pone.0270968.ref008","unstructured":"PREVAC-UP. PARTNERSHIP FOR RESEARCH ON EBOLA VACCINATIONS-EXTENDED FOLLOW-UP: PREVAC-UP; 2020 [cited 2021 4th July 2021]. Available from: https:\/\/prevac-up.eu\/."},{"issue":"2","key":"pone.0270968.ref009","doi-asserted-by":"crossref","first-page":"394","DOI":"10.4269\/ajtmh.15-0703","article-title":"Associations Between Helminth Infections, Plasmodium falciparum Parasite Carriage and Antibody Responses to Sexual and Asexual Stage Malarial Antigens","volume":"95","author":"U Ateba-Ngoa","year":"2016","journal-title":"Am J Trop Med Hyg"},{"issue":"2","key":"pone.0270968.ref010","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1111\/j.1365-3024.2010.01267.x","article-title":"Schistosoma haematobium infection affects Plasmodium falciparum-specific IgG responses associated with protection against malaria","volume":"33","author":"D Courtin","year":"2011","journal-title":"Parasite Immunol"},{"issue":"3","key":"pone.0270968.ref011","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/j.jaci.2016.07.007","article-title":"Regulation of the host immune system by helminth parasites","volume":"138","author":"RM Maizels","year":"2016","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"pone.0270968.ref012","doi-asserted-by":"crossref","first-page":"e0003466","DOI":"10.1371\/journal.pntd.0003466","article-title":"Effect of antenatal parasitic infections on anti-vaccine IgG levels in children: a prospective birth cohort study in Kenya.","volume":"9","author":"I Malhotra","year":"2015","journal-title":"PLoS Negl Trop Dis"},{"issue":"6","key":"pone.0270968.ref013","doi-asserted-by":"crossref","first-page":"e0009361","DOI":"10.1371\/journal.pntd.0009361","article-title":"Exploratory analysis of the effect of helminth infection on the immunogenicity and efficacy of the asexual blood-stage malaria vaccine candidate GMZ2.","volume":"15","author":"O Nouatin","year":"2021","journal-title":"PLoS Negl Trop Dis."},{"issue":"8078","key":"pone.0270968.ref014","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1016\/S0140-6736(78)92403-0","article-title":"Impairment of the immune response to vaccination after acute malaria","volume":"1","author":"WA Williamson","year":"1978","journal-title":"Lancet"},{"issue":"1","key":"pone.0270968.ref015","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1186\/s12916-020-01724-5","article-title":"Antibody responses to a suite of novel serological markers for malaria surveillance demonstrate strong correlation with clinical and parasitological infection across seasons and transmission settings in The Gambia.","volume":"18","author":"L Wu","year":"2020","journal-title":"BMC Med"},{"key":"pone.0270968.ref016","volume-title":"Sierra Leone 2015 Population and Housing Census\u2014national analytical report","author":"Statistics Sierra Leone","year":"2017"},{"key":"pone.0270968.ref017","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1186\/1475-2875-10-223","article-title":"Development of standardized laboratory methods and quality processes for a phase III study of the RTS, S\/AS01 candidate malaria vaccine.","volume":"10","author":"C Swysen","year":"2011","journal-title":"Malar J."},{"issue":"1","key":"pone.0270968.ref018","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s40249-018-0410-y","article-title":"Impact of five annual rounds of mass drug administration with ivermectin on onchocerciasis in Sierra Leone.","volume":"7","author":"JB Koroma","year":"2018","journal-title":"Infect Dis Poverty"},{"issue":"1","key":"pone.0270968.ref019","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1186\/s13071-018-2915-4","article-title":"Progress on elimination of lymphatic filariasis in Sierra Leone.","volume":"11","author":"JB Koroma","year":"2018","journal-title":"Parasit Vectors"},{"key":"pone.0270968.ref020","volume-title":"World Malaria Report. 2021","author":"World Health Organisation","year":"2020"},{"key":"pone.0270968.ref021","volume-title":"Malaria Indicator Survey 2016","author":"Program MoHaSNMC","year":"2016"},{"key":"pone.0270968.ref022","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1186\/s12936-015-1056-x","article-title":"Estimating malaria parasite prevalence from community surveys in Uganda: a comparison of microscopy, rapid diagnostic tests and polymerase chain reaction.","volume":"14","author":"JI Nankabirwa","year":"2015","journal-title":"Malar J"},{"key":"pone.0270968.ref023","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1186\/1475-2875-12-222","article-title":"Seroepidemiological and parasitological evaluation of the heterogeneity of malaria infection in the Gambia.","volume":"12","author":"AR Oduro","year":"2013","journal-title":"Malar J."},{"issue":"12","key":"pone.0270968.ref024","doi-asserted-by":"crossref","first-page":"e2584","DOI":"10.1371\/journal.pntd.0002584","article-title":"Transmission assessment surveys (TAS) to define endpoints for lymphatic filariasis mass drug administration: a multicenter evaluation.","volume":"7","author":"BK Chu","year":"2013","journal-title":"PLoS Negl Trop Dis"},{"key":"pone.0270968.ref025","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.ijid.2020.10.077","article-title":"Simulating a Transmission Assessment Survey: An evaluation of current methods used in determining the elimination of the neglected tropical disease, Lymphatic Filariasis.","volume":"102","author":"PS Weiss","year":"2021","journal-title":"Int J Infect Dis"},{"issue":"11","key":"pone.0270968.ref026","doi-asserted-by":"crossref","first-page":"e891","DOI":"10.1371\/journal.pntd.0000891","article-title":"Geographical distribution of intestinal schistosomiasis and soil-transmitted helminthiasis and preventive chemotherapy strategies in Sierra Leone.","volume":"4","author":"JB Koroma","year":"2010","journal-title":"PLoS Negl Trop Dis"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0270968","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,6]],"date-time":"2022-07-06T17:36:25Z","timestamp":1657128985000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0270968"}},"subtitle":[],"editor":[{"given":"Adrian J.F.","family":"Luty","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2022,7,6]]},"references-count":26,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2022,7,6]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0270968","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,6]]}}}